These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9482700)

  • 1. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; Håkansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC; Wood LJ; Foster M; Gueremy T
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
    Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
    Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human lung fibroblasts on eosinophil degranulation.
    Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
    Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
    J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic dermatitis.
    Miyasato M; Taguchi K; Tsuda S; Kitamura N; Kato K
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):24-6. PubMed ID: 8155999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction.
    Matsunaga Y; Shono M; Takahashi M; Tsuboi Y; Ogawa K; Yamada T
    Br J Pharmacol; 2000 Aug; 130(7):1539-46. PubMed ID: 10928955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
    Agrawal DK; Takami M; Ono S
    Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil degranulation in the presence of lung fibroblasts.
    Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
    Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
    J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines.
    Horie S; Okubo Y; Hossain M; Momose T; Suzuki J; Isobe M; Sekiguchi M
    Immunology; 1997 Feb; 90(2):301-7. PubMed ID: 9135561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I; Olofsson T; Olsson I
    Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.